cells (1 X 107 cells in 1 ml of phosphate-buffered saline) weekly for 5 wk. Animals were bled from the retro-orbital sinus 4 d after the last immunization. In some experiments, diluted serum (75/11, 1:10 in medium 199 with 5% FCS) was absorbed twice with B10.T(6R) lymph node and spleen cells (1 X 108 cells/absorption, 10 min at 4°C) before assay.
Microcytotoxicity Test. A two-stage, dye-exclusion microcytotoxicity test was performed on lymph node cell targets according to Frelinger et al. (4) with modifications suggested by Dr. Donal Murphy (Yale University, New Haven, Conn. Personal communication.) (5) . Fresh guinea pig serum, obtained bimonthly by heart puncture, served as complement. Complement controls were usually <5% dead cells. Between 100 and 200 cells were counted per well, MLC. Mishell-Dutton medium supplemented with 2% FCS and 5 × 10 -s M 2-mercaptoethanol was used throughout (6). X-irradiated (2,000 R), washed splenocytes were pipeted into each of four replicate wells (0.5 × 106 cells/well) ofa microtiter plate (Linbro 76-002-05, Linbro Chemical Co., Hamden, Conn.). Responding lymph node cells were added to each well (0.5 × 10 n cells/well). Total culture vol was 0.2 ml. After 4 d at 37°C in a humidifed atmosphere of 5% CO2 in air, an aliquot of [aH]thymidine (New England Nuclear, Boston, Mass., 25/~1 of 0.04 mCi/ml culture medium) was added to each well. Cultures were harvested 6 h later, and samples were counted in Aquasol (New England Nuclear) in a liquid scintillation counter (model 3330, Packard Instrument Co., Inc., Downers Grove, Ill.).
Results
Certain primary, MLC-proliferative responses ( Fig. 1 ) led us to consider the possibility that an as yet undefined locus might exist between K and I-A. Table I depicts the haplotypes of strains used in these and other experiments (7) . Responding (A.TL X B10.D2)F] cells were stimulated with cells from three strains; stimulating strains were chosen such that genetic differences were limited to discrete H-2 regions (Table I ). B10.T(6R) absorption removes antibody to Qa, T/a, and cross-reactive H-2 q structures that might account for AQR lysis. Because reactivity to I-A k, I-B k, I-J k, I-E k, I-C d, S d, and G a determinants is ruled out (because these alleles are present in the serum-producing F1 hybrid [no autoantibody was observed]), the antigen detected on AQR must map between K and I-A. It is very unlikely that the anti-K k and anti-D k antibodies recognize cross-reactive, I regionencoded AQR antigens. These results provide serologic evidence for an antigen, Ia.W41, encoded by a locus, Ia-7, within a new I subregion, I-N (provisionally designated).
Discussion
The strongest proliferative stimulus in a primary MLC between ceils differing for the entire H-2 complex is encoded by genes in the I region (8) (9) (10) (11) . In view of this finding, the results in Fig. 1 The observation that (A.TL × B10.D2)F1 recipients, immunized with B10.BR, recognize an antigen on AQR that is not present on B10.T(6R), demonstrates a new k haplotype-encoded structure, Ia.W41, which is shared by B 10.BR but not by A.TL. AQR occurred among the progeny of a (T138 X B10.A)Fx to B10 backcross (14) ; it derives genes that include D, Qa, and Tla from B10.A. B10.T(6R) is derived from a cross between gray-lethal test stock and B10.A (15); like AQR, it carried D, Qa, and Tla of B10.A. B10.T(6R) absorption, therefore, rules out the D, Qa, and Tla regions as sites for the Ia.W41-encoding locus. B10.T(6R) and AQR also share K q. Although derived from different sources, these strains show complete cross-reactivity of major transplantation antigens (8) . Thus, Ia.W41 must be encoded by a locus in the AQR genome to the right of K and to the left of D. The serum producer, (A.TL X B10.D2)F1, carries alleles of both the k and d haplotypes from 1-A through G. We conclude, therefore, that the Ia.W41-controlling gene maps between K and l-A; that A.TL carries the s allele, whereas AQR carries the k allele; and finally, that Ia.W41 and the crossovers in recombinants A.TL and AQR distinguish a new I subregion, I-N.
We suggest that the new locus is properly related to the I region. Its product(s) appears to stimulate a strong proliferative response in MLC, and it is present on a subpopulation of lymphoid cells in contrast to the ubiquitous I-I-2K products. Thus, the 1-N subregion, which lies at the boundary between two distinct regions of the H-2 complex in terms of traits under their genetic control, appears to be a refinement of/-region genetic fine structure. The intercalation of I-N between H-2K and I-A will necessitate a systematic reinterpretation and perhaps reevaluation of the H-2 map position of many critically important immunological traits, which have been placed within the K or 1-A regions on the basis of recombinant analysis.
Summary
Strong, primary mixed leukocyte culture-proliferative responses in certain K regionincompatible strain combinations led us to consider whether an I region-like locus might exist between K and I-A. Results obtained with an (A.TL × B10.D2)F1 anti-B I0.BR serum provided serological evidence for a new locus; B10.T(6R)-absorbed serum retained reactivity on AQR lymphocytes. This finding demonstrates an antigen, Ia.W41, encoded by a locus, Ia-7, within a new I subregion, I-N.
